Scripps licenses 'click chemistry' to AL biotech; MN pols wine and dine Baxter;

@FierceBiotech: GlaxoSmithKline picks up FDA panel plug for Breo approval. Story | Follow @FierceBiotech

@RyanMFierce: S. Korean biotech Celltrion "drops" late-stage Rituxan biosim. Can you imagine this happening w/ a s. molecule? Nope. Report | Follow @RyanMFierce

> Huntsville, AL-based biotech Serina Therapeutics has licensed "click chemistry" technology from The Scripps Research Institute. Release

> Minnesota politicians aim to lure Baxter International ($BAX) to set up shop in the state with a package of $15.4 million in tax incentives. Article

Pharma News

@FiercePharma: Baxter to put $300M into old Genmab plant in Minnesota. More | Follow @FiercePharma

@EricPFierce: Is your company among the top 10 pharma companies by employees? If so, where does it fall? Story | Follow @EricPFierce

> Safety watchdog flags GLP-1 drugs for pancreatitis reports to FDA. News

> Will Brazil grab the emerging-markets popularity crown? More

> Sanofi embarks on doc-training in Morocco to boost diabetes, epilepsy care. Article

Vaccines News

> H7N9 cases jump, some show resistance to Roche's Tamiflu. More

> Polio eradication push nearing endgame again. Story

> ITS eyes Big Pharma suitors as universal flu vaccine advances. Article

> India's Biological E pentavalent vaccine takes on GSK, J&J. Item

> Vaccine campaign struggling to contain measles outbreak. More

Pharma Manufacturing News

> Issues with contractor leads to shortage of GSK's Horizant. More

> Sanofi expands in Morocco with €20M hub. News

> Canada's Pharmascience opens new distribution center. Story

> Hikma will keep injectables manufacturing. More

> Contaminated capsules dissolve Biostar earnings. Article

Medical Device News

@FierceMedDev: Combat Medical Systems wins $86M govt. contract. Story | Follow @FierceMedDev

@MarkHFierce: Dx development for the developing world is a hot new area, and the U.K.'s Lumora is diving in. More | Follow @MarkHFierce

 @DamianFierce:  Abbott won FDA approval for a new eye implant, part of its efforts to boost sluggish medical device sales. News | Follow @DamianFierce

> EU faulty implant trial gets colorful amid patients' jeers. Story

> Illumina reaches into China with diagnostics partnership. Item

> Baxter infusion pump, dialysis sales rise slowly. More

And Finally… The Wall Street Journal talked to one of the founders of Living Proof, a hair products company with chemical recipes from the lab of MIT biotech inventor Bob Langer. Item (sub. req.)

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.